Scientists Observe Flaws In System To Protect Labs Against Biohazards

They acknowledge a laxness in following and monitoring research safety guidelines, which could pose a serious risk to some investigators Last spring, when eight students at the University of Pennsylvania's veterinary school went to the school's rural New Bolton Center to castrate some lambs, they considered it to be business as usual. Likewise for the parents and teachers of a nearby preschool class that visited and petted the sheep. What neither group knew was that just a month before, Jorge

Written bySusan L-J Dickinson
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

Scientists at Penn and across the country insist that the breakdown of this protocol resulted in little if any risk to those who came in contact with the animals. Indeed, colleagues say it is because sheep do not contract HTLV-1 that Ferrer was performing this experiment; he was hoping to identify and isolate the immunological compound that protects the sheep from the virus. And neither the vet students nor any of the others who have subsequently been tested are infected with HTLV-1.

Any scientist fed up with the current regulatory system governing work with biohazards may want to take a page from plant pathologist Gary Strobel's book and disregard the system altogether. Though he broke the law and endangered all federally funded work at Montana State University, all Strobel has to show for it today are the souvenirs of a hero: increased recognition throughout the scientific community, some 200 letters ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies